Page 277 - Abstract Book KONIKA 18
P. 277

Infection & Tropical Disease

                                               P-ITD-043
                     Clinical and Laboratory Profiles of Cytomegalovirus Infection
                                     in Ulin Hospital Banjarmasin

                                         Sitti Amelia Mc, Edi Hartoyo
                       Department of Child Health, Universitas Lambung mangkurat, Ulin General Hospital,
                                      Banjarmasin, South Borneo, Indonesia.

                                               Abstract
            Background Citomegalovirus (CMV) is an infection that raises a heavy burden for children and families. The
            MCV infection’s manifestation are jaundice, thrombocytopenia, microchephaly, and intracranial calcification.
            In Indonesia, data about clinical and laboratory profile of CMV infection is insufficiently complete, especially
            in RSUD Ulin Banjarmasin. Objective This study aimed to know about clinical and laboratory profile of
            CMV infection in RSUD Ulin. Methods A descriptive observational study was conducted by seeing patient’s
            medical record.  The subject must be under 18 years old and diagnosed CMV infection in RSUD Ulin from
            January 2019 to August 2021. Results During the study period there were 16 patients with CMV infection.
            The most prominent manifestation were microchepaly, hepatosplenomegaly, jaundice and deafness. From
            laboratory examination we found elevated bilirubin, elevated IgG anti CMV, elevated ALP/AST, elevated
            PT/APTT and anemia. Conclusion Patient characteristic which is mostly found <12 months of age, male,
            and severe underweight. Laboratory manifestation found elevated bilirubin profile and elevated ALP/AST.
            Serology examination found elevated IgG anti CMV.
                    Keywords: cytomegalovirus (CMV); characteristic patient; clinical profiles; laboratory profiles;
                                            children; descriptive


                                                P-ITD-044
                    A Case of Dengue Shock Syndrome Co-Infection  with COVID-19
                                  in an 8-year and 11-months-old Girl

                                     Rosalia Sri Wahyuni N, Ninny Meutia P
             Department of Children’s Health, Faculty of Medicine, Universitas Hasanuddin/Dr. Wahidin Sudirohusodo Hospital,
                                       Makassar, South Sumatera, Indonesia
                                               Abstract
            Background Dengue fever is common in Indonesia, estimated at 77,96/100.000 person in 2016. In 2020,
            SARS CoV-2 has infected more than 172,053 person by August 30th 2020 in Indonesia, and expected to grow
            exponentially unless strict measurements were implemented. There are similar symptoms and laboratory
            findings in both dengue fever and COVID 19, which might lead to a missed diagnosis. This is especially
            worrisome in the context of the pandemic, where COVID-19 possibly endanger communities and health
            care workers. Objective We present cases of patients who initially presented with symptoms and laboratory
            finding of dengue shock syndrome. During the course of illness these patients show characteristic dengue
            symptoms, and the two cases did not show any abnormality to pneumonia. This could be explained by an
            asymptomatic COVID-19. Case An 8-years 11-months-old girl was admitted to the hospital with a fever since
            4 days ago, bloody nose, and black vomit for 3 times. Her neighbours are Dengue positive, no COVID-19
            positive. Laboratory findings are anemia, thrombocytopenia, hypoalbuminemia and increased transaminase
            enzymes. Thorax CT scan shows a bilateral pleural effusion, pneumonia, and fibrosis. The patient was given
            Oseltamivir, fluid management for Dengue, and symptomatic treatments. The patient was discharged on
            9th day, and was self- isolated at home with no symptoms. Conclusion As lesson learned, differentiating
            dengue fever and COVID-19 infection is difficult. Every patient with fever should be tested for COVID-19.
            Oseltamivir is recommended to use in mild, moderate, severe, even critical COVID-19 patients.
                                      Keywords: dengue; COVID; case report









                                           KONIKA XVIII Abstract Book                                                                     229
   272   273   274   275   276   277   278   279   280   281   282